SARS-CoV-2-IN-106

SARS-CoV-2-IN-106

• CAS Number: 2863607-73-0
• UNSPSC Description: SARS-CoV-2-IN-106 (compound 19) is a SARS-CoV-2 papain-like protease inhibitor with the IC50 values of 0.44 μM and 0.18 μM for PLpro enzymatic and viral replication ,respectively[1].
• Target Antigen: SARS-CoV
• Type: Reference compound
• Related Pathways: Anti-infection
• Applications: COVID-19-anti-virus
• Field of Research: Infection
• Assay Protocol: https://www.medchemexpress.com/sars-cov-2-in-106.html
• Smiles: C[C@@H](N1CCC(CC1)C(NCC2=CC(NC(N3CCN(CC3)C)=O)=CC(F)=C2)=O)C4=CC=CC5=C4C=CC=C5
• Molecular Weight: 531.66
• References & Citations: [1]Shan H, et al. Development of potent and selective inhibitors targeting the papain-like protease of SARS-CoV-2. Cell Chem Biol. 2021;28(6):855-865.e9.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported